| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30058134 | HIV | ENSG00000163406.11 | protein_coding | SLC15A2 | No | No | 6565 | Q16348 |
| TVIS20001274 | HPV | ENSG00000163406.11 | protein_coding | SLC15A2 | No | No | 6565 | Q16348 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC15A2 |
|---|---|
| DrugBank ID | DB00713 |
| Drug Name | Oxacillin |
| Target ID | BE0001134 |
| UniProt ID | Q16348 |
| Regulation Type | |
| PubMed IDs | 21741846 |
| Citations | Pedretti A, De Luca L, Marconi C, Regazzoni L, Aldini G, Vistoli G: Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping. Bioorg Med Chem. 2011 Aug 1;19(15):4544-51. doi: 10.1016/j.bmc.2011.06.027. Epub 2011 Jun 16. |
| Groups | Approved; Investigational |
| Direct Classification | Dipeptides |
| SMILES | [H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O |
| Pathways | |
| PharmGKB | PA450725 |
| ChEMBL | CHEMBL819 |
